Most importantly, the significant biological impacts of the METTL14/ZFP14 axis and ZFP14/STAT3 axis provide valuable insights for ccRCC therapy, which was the original intention of this study. The gene discussed is STAT3; the disease is nonpapillary renal cell carcinoma.